文献速递分子诊断临床血液与体液

基于GAP-PCR与MALDI-TOF MS的基因筛查与血细胞筛查在越南早孕地中海贫血中的比较

Gene-based screening using GAP-PCR and MALDI-TOF MS versus haemogram-based screening for thalassaemia in early pregnancy in Vietnam.
PubMed 文献 · Clin Chim Acta · 2026-05-15

在越南河内妇产医院572例早孕期孕妇中开展前瞻性诊断准确性研究,比较GAP-PCR联合MALDI-TOF MS检测24种常见α/β地中海贫血突变与血细胞指数筛查。基因检测检出携带者101例(17.7%),血液学筛查标记203例疑似(35.5%);β地贫灵敏度100%,α地贫90.6%,两者特异度均为77.1%,PPV低(≤25.1%),NPV超过98.9%。基因筛查可识别血细胞指数正常而被漏检的静止型携带者。

要点

  • 基因筛查检出携带者17.7%,血液学筛查标记疑似35.5%。
  • β地贫灵敏度100%,α地贫90.6%,特异度均77.1%。
  • 6例α地贫携带者血细胞指数正常,被血液学筛查漏检。

核心结论

  • 基因筛查提高诊断准确性,可识别血细胞筛查漏检的静止型携带者。
  • 在高流行地区产前筛查中可能具有应用价值,但成本效益与可行性需进一步评估。

研究设计与样本

  • 前瞻性诊断准确性研究,纳入572例早孕期孕妇(越南河内妇产医院)。
  • 所有参与者同时接受血细胞筛查(MCV<80 fL或MCH<28 pg为阳性)和GAP-PCR联合MALDI-TOF MS检测24种常见α/β地贫突变。

主要发现

  • 基因检测检出携带者101例(17.7%):α地贫64例(11.2%)、β地贫34例(5.9%)、复合3例(0.5%)。
  • 主要突变为-SEA缺失(占α地贫46.3%)和HbE变异(占β地贫48.6%)。
  • 血液学筛查标记疑似203例(35.5%)。
  • β地贫灵敏度100%,α地贫灵敏度90.6%,两者特异度均为77.1%。
  • PPV低(≤25.1%),NPV超过98.9%;6例基因携带者(均为α地贫)血细胞指数正常。

关键数值与推荐

  • 血细胞筛查阳性定义:MCV<80 fL或MCH<28 pg。
  • 基因筛查覆盖24种常见α-和β-地贫突变,采用GAP-PCR联合MALDI-TOF MS。

临床怎么用

  • 在早孕期产前筛查中,可考虑基因筛查以弥补血细胞筛查对静止型携带者的漏检。
  • 血细胞筛查阴性不能排除α地贫携带,尤其在高流行区。

局限性

  • 成本效益与可行性需进一步评估。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Thalassaemia is a common inherited disorder in Southeast Asia, including Vietnam. Conventional haemogram-based screening is widely used in routine prenatal care but has limited specificity and may be confounded by other conditions. This study compared gene-based screening using gap polymerase chain reaction (GAP-PCR) and matrix-assisted laser desorption ionization time-of-flight mass spectrometry (MALDI-TOF MS) with haematologic indices for thalassaemia carrier detection in early pregnancy. METHODS: A prospective diagnostic accuracy study was conducted amongst 572 first-trimester pregnant women at Hanoi Obstetrics and Gynecology Hospital. All participants underwent both haemogram-based screening (defined as positive when mean corpuscular volume (MCV) <80 fL or mean corpuscular haemoglobin (MCH) <28 pg) and gene-based screening for 24 common α- and β-thalassaemia mutations using GAP-PCR combined with MALDI-TOF MS. Sensitivity, specificity, positive predictive value (PPV), and negative predictive value (NPV) were compared. RESULTS: Gene testing identified 101 carriers (17.7%): 64 α-thalassaemia (11.2%), 34 β-thalassaemia (5.9%), and 3 combined (0.5%). The predominant mutations were -SEA deletion (46.3% of α-thalassaemia) and HbE variant (48.6% of β-thalassaemia). Haematologic screening flagged 203 suspected cases (35.5%). Sensitivity was 100% for β-thalassaemia and 90.6% for α-thalassaemia, with a specificity of 77.1% for both. Six genetic carriers (all α-thalassaemia) had normal haematologic indices. PPVs were low (≤25.1%), while NPVs exceeded 98.9%. CONCLUSION: Gene-based screening enhances diagnostic accuracy and identifies silent carriers missed by haemogram-based methods. These findings suggest a potential role in antenatal screening in high-prevalence settings, although cost-effectiveness and feasibility require further evaluation.

来源:Clin Chim Acta,查看原文。版权归原作者所有。

引用

  1. Mai TH, Lam TT, Nguyen TD, et al. Gene-based screening using GAP-PCR and MALDI-TOF MS versus haemogram-based screening for thalassaemia in early pregnancy in Vietnam. Clin Chim Acta. 2026. PMID: 42142697. doi:10.1016/j.cca.2026.121088

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。